Evidence map›Paper›PMID 27134622›Full record

ArticleAdvanced functional materials2016

Highly scalable, closed-loop synthesis of drug-loaded, layer-by-layer nanoparticles.

Santiago Correa, Ki Young Choi, Erik C Dreaden, Kasper Renggli, Aria Shi, Li Gu, Kevin E Shopsowitz, Mohiuddin A Quadir, Elana Ben-Akiva, Paula T Hammond

Abstract read
In one paragraph

Article in Advanced functional materials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Charge-Stabilized Nanodiscs as a New Class of Lipid Nanoparticles.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
  8. Surfactant-Mediated Assembly of Precision-Size Liposomes.Chemistry of materials : a publication of the American Chemical Society · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Santiago CorreaInstitute for Integrative Cancer Research Department of Biological Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Ki Young ChoiKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Erik C DreadenKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Kasper RenggliKoch Institute for Integrative Cancer Research Department of Biological Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Aria ShiKoch Institute for Integrative Cancer Research Department of Biological Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Li GuKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Kevin E ShopsowitzKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Mohiuddin A QuadirKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Elana Ben-AkivaKoch Institute for Integrative Cancer Research Department of Biological Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.
Paula T HammondKoch Institute for Integrative Cancer Research Department of Chemical Engineering Massachusetts Institute of Technology Cambridge, MA, 02139, USA.

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Jacqueline A. Lees · 1985 to 2026
$93.9M
LbL Nanotechnologies for Synergistic Therapy of Advanced Ovarian CarcinomaF32EB017614 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI DREADEN, ERIK CHRISTOPHER · 2013 to 2014
$102k
NCI NIH HHS P30 CA014051NIBIB NIH HHS F32 EB017614
6 · The paper itself

Abstract

Layer-by-layer (LbL) self-assembly is a versatile technique from which multicomponent and stimuli-responsive nanoscale drug carriers can be constructed. Despite the benefits of LbL assembly, the conventional synthetic approach for fabricating LbL nanoparticles requires numerous purification steps that limit scale, yield, efficiency, and potential for clinical translation. In this report, we describe a generalizable method for increasing throughput with LbL assembly by using highly scalable, closed-loop diafiltration to manage intermediate purification steps. This method facilitates highly controlled fabrication of diverse nanoscale LbL formulations smaller than 150 nm composed from solid-polymer, mesoporous silica, and liposomal vesicles. The technique allows for the deposition of a broad range of polyelectrolytes that included native polysaccharides, linear polypeptides, and synthetic polymers. We also explore the cytotoxicity, shelf life and long-term storage of LbL nanoparticles produced using this approach. We find that LbL coated systems can be reliably and rapidly produced: specifically, LbL-modified liposomes could be lyophilized, stored at room temperature, and reconstituted without compromising drug encapsulation or particle stability, thereby facilitating large scale applications. Overall, this report describes an accessible approach that significantly improves the throughput of nanoscale LbL drug-carriers that show low toxicity and are amenable to clinically relevant storage conditions.

Indexed as

biomaterialscolloid chemistrylayer-by-layer nanoparticlespolymer engineeringscalable synthesis

Identifiers

PMID27134622
PMCPMC4847955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.